Release date: July 15, 2011
Expiration date: December 31, 2012
Estimated time to complete activity: 0.5 hours
Jointly sponsored by the University of Virginia Health System and CME Enterprise
The CS2day initiative is supported by an educational grant from Pfizer Inc.
Faculty
Bruce A. Berger, PhD, RPh
Emeritus Professor of Pharmacy Care Systems,
Auburn University
President, Berger Consulting, LLC
Auburn, Alabama
Activity Details
Target Audience
This activity is designed for a broad audience that includes physicians, nurses, pharmacists,
and any other clinician whose scope of practice includes helping patients quit smoking or make
other health behavior changes.
Overview
Cease Smoking Today (CS2day) is a collaborative partnership designed to reduce the number of
persons who smoke and decrease morbidity and mortality from smoking-related illness through
numerous integrated educational interventions. This brief activity will introduce the concept
of motivational interviewing (MI) and its value in helping patients who smoke to consider a
quit attempt, as well as its application to other areas of health behavior change. Key components
of MI will be explained, and video demonstrations of successful MI will be shown. Participants
will be encouraged to consider how to integrate MI into their practice setting, and additional
resources will be shared for those wanting to learn more.
Learning Objectives
At the conclusion of this activity, participants should be able to
- Identify barriers and facilitators to health behavior change.
- Describe the spirit and skills of MI as they apply to smoking cessation and other health behavior changes.
- Differentiate between what MI is and what it is not.
Accreditation Statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the University of Virginia
Health System in cooperation with CME Enterprise. The University of Virginia Health System is accredited
by the ACCME to provide continuing medical education for physicians.
This program was planned in accordance with American Academy of Nurse Practitioners (AANP) CE Standards
and Policies and AANP Commercial
Support Standards.
Credit Designation Statements
The University of Virginia Health System designates this enduring material for a maximum of 0.5 AMA PRA
Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
This enduring material activity, Motivational Interviewing in Health Care: What Is It and Why Use It?, has
been reviewed and is acceptable for up to .50 Prescribed
credit(s) by the American Academy of Family Physicians.
AAFP accreditation begins June 15, 2011. The term of approval is for one year(s) from this date, with option
for yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
Purdue University
College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of
continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University,
an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-11-005-H04-P, 0.5
contact hours (0.050 CEU). Approval is valid from the initial release date of July 15, 2011. The expiration
date is December 31, 2012.
The Interstate Postgraduate Medical Association is approved by the California Board of Registered Nursing,
Provider number 6971, for 0.6 contact hours. Each person should retain this certificate for 4 years after
the course has been completed.
This program has been approved for 0.5 contact hours of continuing education
(which includes 0.25 hours of
pharmacology) by the American Academy of Nurse Practitioners. Program ID 1105149.
Disclosure of Conflicts of Interest
-
Bruce A. Berger, PhD, RPh
| Consultant/Speakers Bureau |
Amylin Pharmaceuticals; sanofi-aventis |
| President |
Berger Consulting, LLC |
- The planning staff of the University of Virginia Health System and CME Enterprise have nothing to disclose.
Disclosure of Unlabeled Use
The audience is advised that this continuing medical education activity will not include reference(s)
to unlabeled or unapproved uses of drugs or devices.
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect
the views or recommendations of the University of Virginia Health System, CME Enterprise, or the commercial
supporter.
Method of Participation
There are no fees or prerequisites for participating in and receiving CME credit for this online
educational activity. In order to obtain CME credit for participating in this activity during the
period of July 15, 2011, through December 31, 2012, participants must
- Read the educational objectives and disclosure statements.
- Study the educational activity.
- Proceed to the University of Virginia Health System’s Web site
to answer each posttest question and complete the activity evaluation.
Credit will be issued only upon receipt of a posttest with a score of 70% or higher and a completed
activity evaluation. After submitting these forms, you will be able to print out your credit certificate.
This activity should take approximately 30 minutes to complete. Approximately
25 minutes should be spent
participating in the activity. The remaining 5 minutes should be used to complete the activity posttest
and evaluation. As part of this activity, you will receive a follow-up e-mail approximately 12 weeks
following completion to remind you of the content and inquire about its application in your practice.
For questions regarding the content of this activity, contact the accredited provider for this CME activity, the
University of Virginia Health System, by e-mailing cac9f@virginia.edu.
Computer Requirements
To access this activity, users will need
Help
For technical assistance, e-mail Katie Fanning at katie_fanning@cmeenterprise.com.